促红细胞生成素治疗间接性外伤性视神经病变的应用进展  

Application progress of erythropoietin in the treatment of indirect traumatic optic neuropathy

作　　者：张宇鹏 邓爱军[1] 孙艳[1] Zhang Yupeng;Deng Aijun;Sun Yan(Eye center of Affiliated Hospital of Weifang Medical College,Weifang Medical College,Weifang 261402,China)

机构地区：[1]潍坊医学院附属医院眼科中心,261042

出　　处：《中华眼科医学杂志（电子版）》2023年第1期45-49,共5页Chinese Journal of Ophthalmologic Medicine(Electronic Edition)

基　　金：山东省自然科学基金项目(ZR2020MH173)。

摘　　要：外伤性视神经病变是颅脑颌面部外伤后重要并发症之一,目前对于其治疗仍然是全球范围内的一大难题,尚未形成统一的诊疗指南。部分临床试验证实,促红细胞生成素在治疗眼科疾病方面具有独特的疗效,有助于视功能的恢复和改善,本文中笔者就促红细胞生成素治疗间接性外伤性视神经病变(TON)应用进展进行综述,旨在探讨EPO治疗间接性外伤性视神经病变(ITON)患者的临床应用,以期为EPO干预治疗ITON提供新的方向。Traumatic optic neuropathy is one of the important complications after craniofacial trauma,and its treatment remains a major challenge worldwide,no unified diagnosis and treatment guidelines has been yet established.Some clinical trials have confirmed that erythropoietin has a unique therapeutic effect in the treatment of ophthalmic diseases,which contributes to the recovery and improvement of visual function.The application progress of erythropoietin in the treatment of indirect traumatic optic neuropathy(TON)was reviewed,which to explore the clinical application of EPO in the treatment of indirect traumatic optic neuropathy(ITON)patients,in order to provide new directions for EPO intervention in the treatment of ITON.

关 键 词：外伤性视神经病变 神经节细胞 促红细胞生成素 神经保护 

分 类 号：R77[医药卫生—眼科]